Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation

BACKGROUND: The combination of gemcitabine and docetaxel is often used to treat patients with recurrent sarcoma. Nab-paclitaxel is a taxane modified to improve drug exposure and increase intratumoral accumulation and, in combination with gemcitabine, is standard therapy for pancreatic cancer. Applyi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pediatr Blood Cancer
Egile Nagusiak: Oesterheld, Javier E., Reed, Damon R., Setty, Bhuvana A., Isakoff, Michael S., Thompson, Patrick, Yin, Hong, Hayashi, Masanori, Loeb, David M., Smith, Tiffany, Makanji, Rikesh, Fridley, Brooke L., Wagner, Lars M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7771264/
https://ncbi.nlm.nih.gov/pubmed/32386107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.28370
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak